# NICE Ltd.: Form 20-F for the period ended Dec 31, 2023

- Company: [NICE Ltd.](/companies/nice.md) (CIK 1003935)
- Form: 20-F
- Filed: 2024-03-27
- Accepted by EDGAR: Mar 27, 2024, 16:11 ET
- Period: 2023-12-31
- Accession: 0001628280-24-013301
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1003935/000162828024013301/nice-20231231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1003935/000162828024013301/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2023-01-01 to 2023-12-31 | $2.38bn | us-gaap:Revenues |
| Cost of revenue | 12 months, 2023-01-01 to 2023-12-31 | $768.2m | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2023-01-01 to 2023-12-31 | $1.61bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2023-01-01 to 2023-12-31 | $322.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2023-01-01 to 2023-12-31 | $435.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2023-01-01 to 2023-12-31 | $1.1m | us-gaap:InterestExpense |
| Income tax | 12 months, 2023-01-01 to 2023-12-31 | $119.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2023-01-01 to 2023-12-31 | $336.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2023-01-01 to 2023-12-31 | $5.11 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2023-01-01 to 2023-12-31 | $5.32 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2023-01-01 to 2023-12-31 | 66,265,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2023-01-01 to 2023-12-31 | $561.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2023-01-01 to 2023-12-31 | $29.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months, 2023-01-01 to 2023-12-31 | $288.4m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2023-12-31 | $511.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2023-12-31 | $2.31bn | us-gaap:AssetsCurrent |
| Total assets | at 2023-12-31 | $5.12bn | us-gaap:Assets |
| Current liabilities | at 2023-12-31 | $1.12bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2023-12-31 | $457.1m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2023-12-31 | $209.2m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2023-12-31 | $3.34bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2023-12-31 | 62,870,669 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1003935/000162828024013301/nice-20231231.htm

Filed Mar 27, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-013301. Last ingested by Listed: Oct 29, 2026, 16:35 ET. No prices; not investment advice.